

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.13019369 |
| 2 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.55244516 |
| 3 | vocalization behavior (GO:0071625) | 5.45042952 |
| 4 | locomotory exploration behavior (GO:0035641) | 5.40900237 |
| 5 | synaptic vesicle maturation (GO:0016188) | 5.40464575 |
| 6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.34114538 |
| 7 | synaptic vesicle exocytosis (GO:0016079) | 5.22157357 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.16631019 |
| 9 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.15395907 |
| 10 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.11342819 |
| 11 | glutamate secretion (GO:0014047) | 5.09468999 |
| 12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.89713307 |
| 13 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.73417613 |
| 14 | protein localization to synapse (GO:0035418) | 4.65203536 |
| 15 | regulation of synaptic vesicle transport (GO:1902803) | 4.59872158 |
| 16 | neuronal action potential propagation (GO:0019227) | 4.54216850 |
| 17 | neuron cell-cell adhesion (GO:0007158) | 4.50624474 |
| 18 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.44035117 |
| 19 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.37341828 |
| 20 | exploration behavior (GO:0035640) | 4.31882139 |
| 21 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.30481112 |
| 22 | synaptic transmission, glutamatergic (GO:0035249) | 4.28026489 |
| 23 | glutamate receptor signaling pathway (GO:0007215) | 4.21424695 |
| 24 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.08024751 |
| 25 | neurotransmitter secretion (GO:0007269) | 4.06267052 |
| 26 | layer formation in cerebral cortex (GO:0021819) | 3.95079249 |
| 27 | dendritic spine morphogenesis (GO:0060997) | 3.92130761 |
| 28 | neuron-neuron synaptic transmission (GO:0007270) | 3.90620448 |
| 29 | positive regulation of membrane potential (GO:0045838) | 3.89429637 |
| 30 | epithelial cell differentiation involved in kidney development (GO:0035850) | 3.87341529 |
| 31 | long-term memory (GO:0007616) | 3.87320521 |
| 32 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.83455317 |
| 33 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.80776984 |
| 34 | proline transport (GO:0015824) | 3.73016955 |
| 35 | positive regulation of synapse maturation (GO:0090129) | 3.69368861 |
| 36 | regulation of synaptic plasticity (GO:0048167) | 3.64222908 |
| 37 | regulation of postsynaptic membrane potential (GO:0060078) | 3.63318114 |
| 38 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.62911096 |
| 39 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.61983622 |
| 40 | neuron recognition (GO:0008038) | 3.59849420 |
| 41 | long-term synaptic potentiation (GO:0060291) | 3.58064492 |
| 42 | presynaptic membrane assembly (GO:0097105) | 3.57938321 |
| 43 | regulation of synapse structural plasticity (GO:0051823) | 3.56602753 |
| 44 | synaptic vesicle endocytosis (GO:0048488) | 3.52653846 |
| 45 | innervation (GO:0060384) | 3.51734601 |
| 46 | auditory behavior (GO:0031223) | 3.49460369 |
| 47 | chemosensory behavior (GO:0007635) | 3.47837646 |
| 48 | activation of protein kinase A activity (GO:0034199) | 3.47766276 |
| 49 | L-amino acid import (GO:0043092) | 3.47551535 |
| 50 | regulation of female receptivity (GO:0045924) | 3.46044473 |
| 51 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.44185574 |
| 52 | postsynaptic membrane organization (GO:0001941) | 3.40809145 |
| 53 | cellular potassium ion homeostasis (GO:0030007) | 3.40220777 |
| 54 | detection of calcium ion (GO:0005513) | 3.38920560 |
| 55 | neurotransmitter transport (GO:0006836) | 3.32633256 |
| 56 | regulation of neurotransmitter secretion (GO:0046928) | 3.32362583 |
| 57 | regulation of vesicle fusion (GO:0031338) | 3.31490793 |
| 58 | dendritic spine organization (GO:0097061) | 3.30998465 |
| 59 | sleep (GO:0030431) | 3.30007063 |
| 60 | opioid receptor signaling pathway (GO:0038003) | 3.29457777 |
| 61 | presynaptic membrane organization (GO:0097090) | 3.28567208 |
| 62 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.23897096 |
| 63 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.20559050 |
| 64 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.19704937 |
| 65 | axonal fasciculation (GO:0007413) | 3.19376484 |
| 66 | gamma-aminobutyric acid transport (GO:0015812) | 3.18249299 |
| 67 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.15968037 |
| 68 | long term synaptic depression (GO:0060292) | 3.15696778 |
| 69 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.15211838 |
| 70 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.15111778 |
| 71 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.12700431 |
| 72 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.10431059 |
| 73 | transmission of nerve impulse (GO:0019226) | 3.09552300 |
| 74 | serotonin metabolic process (GO:0042428) | 3.09515798 |
| 75 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.06619207 |
| 76 | regulation of ARF protein signal transduction (GO:0032012) | 3.06009302 |
| 77 | startle response (GO:0001964) | 3.04895894 |
| 78 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.04543958 |
| 79 | sodium ion export (GO:0071436) | 3.04430012 |
| 80 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.04193668 |
| 81 | potassium ion import (GO:0010107) | 3.04101740 |
| 82 | response to histamine (GO:0034776) | 3.03404547 |
| 83 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.01632875 |
| 84 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.01625479 |
| 85 | * G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.00815005 |
| 86 | membrane depolarization (GO:0051899) | 2.99623687 |
| 87 | regulation of neurotransmitter levels (GO:0001505) | 2.98370113 |
| 88 | glycosphingolipid biosynthetic process (GO:0006688) | 2.98271531 |
| 89 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.98190339 |
| 90 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.97864992 |
| 91 | C4-dicarboxylate transport (GO:0015740) | 2.97404357 |
| 92 | cerebellar granule cell differentiation (GO:0021707) | 2.96812740 |
| 93 | urinary tract smooth muscle contraction (GO:0014848) | 2.96359088 |
| 94 | regulation of neurotransmitter transport (GO:0051588) | 2.95453077 |
| 95 | positive regulation of neurotransmitter transport (GO:0051590) | 2.95199215 |
| 96 | mechanosensory behavior (GO:0007638) | 2.94236544 |
| 97 | cell migration in hindbrain (GO:0021535) | 2.94210629 |
| 98 | neuromuscular process controlling balance (GO:0050885) | 2.93924127 |
| 99 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.93633636 |
| 100 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.93461864 |
| 101 | behavioral defense response (GO:0002209) | 2.93351502 |
| 102 | behavioral fear response (GO:0001662) | 2.93351502 |
| 103 | positive regulation of synaptic transmission (GO:0050806) | 2.93198871 |
| 104 | regulation of synaptic transmission (GO:0050804) | 2.93124875 |
| 105 | regulation of dendritic spine development (GO:0060998) | 2.92767103 |
| 106 | learning (GO:0007612) | 2.92169358 |
| 107 | vesicle transport along microtubule (GO:0047496) | 2.91853427 |
| 108 | dendrite morphogenesis (GO:0048813) | 2.89340061 |
| 109 | fear response (GO:0042596) | 2.88948337 |
| 110 | neurofilament cytoskeleton organization (GO:0060052) | 2.88419382 |
| 111 | positive regulation of dendritic spine development (GO:0060999) | 2.88020867 |
| 112 | cochlea development (GO:0090102) | 2.87741785 |
| 113 | regulation of synapse maturation (GO:0090128) | 2.87368565 |
| 114 | response to auditory stimulus (GO:0010996) | 2.87357624 |
| 115 | synaptic transmission (GO:0007268) | 2.86842334 |
| 116 | regulation of exocytosis (GO:0017157) | 2.86571878 |
| 117 | neuronal ion channel clustering (GO:0045161) | 2.85662563 |
| 118 | regulation of cilium movement (GO:0003352) | 2.84294992 |
| 119 | membrane depolarization during action potential (GO:0086010) | 2.83451830 |
| 120 | cerebellar Purkinje cell layer development (GO:0021680) | 2.83108912 |
| 121 | aggressive behavior (GO:0002118) | 2.82091227 |
| 122 | female mating behavior (GO:0060180) | 2.81272434 |
| 123 | intraspecies interaction between organisms (GO:0051703) | 2.80879761 |
| 124 | social behavior (GO:0035176) | 2.80879761 |
| 125 | positive regulation of exocytosis (GO:0045921) | 2.79771814 |
| 126 | synapse assembly (GO:0007416) | 2.79658286 |
| 127 | acidic amino acid transport (GO:0015800) | 2.76822939 |
| 128 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.75435426 |
| 129 | neuromuscular process (GO:0050905) | 2.73699050 |
| 130 | primary amino compound metabolic process (GO:1901160) | 2.72213919 |
| 131 | negative regulation of dendrite development (GO:2000171) | 2.71674437 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.23909861 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.76260630 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.00523275 |
| 4 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.95311591 |
| 5 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.85085532 |
| 6 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.77487820 |
| 7 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.52124012 |
| 8 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.52124012 |
| 9 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.51196638 |
| 10 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.51006852 |
| 11 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.47999123 |
| 12 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.47869344 |
| 13 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.44025085 |
| 14 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.43058869 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.37685156 |
| 16 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.36683782 |
| 17 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.31589808 |
| 18 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.17869225 |
| 19 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.14465486 |
| 20 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.14044804 |
| 21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.13232539 |
| 22 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.12243532 |
| 23 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.97009266 |
| 24 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.85713278 |
| 25 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.83164429 |
| 26 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.79942363 |
| 27 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.78366562 |
| 28 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.78069961 |
| 29 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.73142695 |
| 30 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.70726642 |
| 31 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.69856803 |
| 32 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.68146931 |
| 33 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.67956882 |
| 34 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.58094895 |
| 35 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.56520052 |
| 36 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.52727150 |
| 37 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.47083171 |
| 38 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.46756277 |
| 39 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.44391282 |
| 40 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.42492735 |
| 41 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.40651830 |
| 42 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.40438874 |
| 43 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.36049498 |
| 44 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.34955671 |
| 45 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.34531113 |
| 46 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.33463627 |
| 47 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.31494549 |
| 48 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.31363499 |
| 49 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.30399017 |
| 50 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.30238123 |
| 51 | AR_25329375_ChIP-Seq_VCAP_Human | 1.28104196 |
| 52 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.27913749 |
| 53 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.24213437 |
| 54 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.23068970 |
| 55 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22642974 |
| 56 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.22570604 |
| 57 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22171971 |
| 58 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.21077801 |
| 59 | AR_19668381_ChIP-Seq_PC3_Human | 1.20187880 |
| 60 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19005685 |
| 61 | EWS_26573619_Chip-Seq_HEK293_Human | 1.17102683 |
| 62 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.16228561 |
| 63 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.16223434 |
| 64 | TCF4_23295773_ChIP-Seq_U87_Human | 1.15907492 |
| 65 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.14713011 |
| 66 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.14649906 |
| 67 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.13690831 |
| 68 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.12959775 |
| 69 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.12122711 |
| 70 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.12120932 |
| 71 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.11883371 |
| 72 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.11858923 |
| 73 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.11775220 |
| 74 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.10544417 |
| 75 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.09961420 |
| 76 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.09887034 |
| 77 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.08700595 |
| 78 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08647252 |
| 79 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.07254872 |
| 80 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.07254872 |
| 81 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.07244828 |
| 82 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.07096264 |
| 83 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.06680937 |
| 84 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.06139167 |
| 85 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05429168 |
| 86 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.05241831 |
| 87 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.03532843 |
| 88 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.02833228 |
| 89 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.02695413 |
| 90 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02691485 |
| 91 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.02603850 |
| 92 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.02489339 |
| 93 | KDM2B_26808549_Chip-Seq_REH_Human | 1.01947752 |
| 94 | FUS_26573619_Chip-Seq_HEK293_Human | 1.00528656 |
| 95 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.00424124 |
| 96 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.99882865 |
| 97 | TP53_16413492_ChIP-PET_HCT116_Human | 0.99518587 |
| 98 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.99358014 |
| 99 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.98112040 |
| 100 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.97461661 |
| 101 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.96977594 |
| 102 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.96929394 |
| 103 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95936847 |
| 104 | * BCAT_22108803_ChIP-Seq_LS180_Human | 0.94826042 |
| 105 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.94186637 |
| 106 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.92547507 |
| 107 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 0.91995585 |
| 108 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.91845534 |
| 109 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.91324259 |
| 110 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91324259 |
| 111 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91202656 |
| 112 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.90993947 |
| 113 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.89973221 |
| 114 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.89867129 |
| 115 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.89136822 |
| 116 | KDM2B_26808549_Chip-Seq_K562_Human | 0.88209981 |
| 117 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.88030223 |
| 118 | RXR_22108803_ChIP-Seq_LS180_Human | 0.86957144 |
| 119 | VDR_22108803_ChIP-Seq_LS180_Human | 0.86639707 |
| 120 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85703100 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.80207572 |
| 2 | MP0003880_abnormal_central_pattern | 4.83953452 |
| 3 | * MP0003635_abnormal_synaptic_transmissio | 4.13861111 |
| 4 | MP0004270_analgesia | 3.97690912 |
| 5 | * MP0002063_abnormal_learning/memory/cond | 3.32394743 |
| 6 | MP0009745_abnormal_behavioral_response | 3.31664707 |
| 7 | MP0002064_seizures | 3.02879604 |
| 8 | MP0009780_abnormal_chondrocyte_physiolo | 2.99843337 |
| 9 | MP0002572_abnormal_emotion/affect_behav | 2.74157691 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.71876206 |
| 11 | MP0002734_abnormal_mechanical_nocicepti | 2.55110330 |
| 12 | MP0009046_muscle_twitch | 2.54123971 |
| 13 | MP0001486_abnormal_startle_reflex | 2.45676912 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.45117800 |
| 15 | * MP0002272_abnormal_nervous_system | 2.37157103 |
| 16 | MP0002909_abnormal_adrenal_gland | 2.36714041 |
| 17 | * MP0001501_abnormal_sleep_pattern | 2.18899778 |
| 18 | MP0002736_abnormal_nociception_after | 2.10466830 |
| 19 | MP0002822_catalepsy | 2.00125009 |
| 20 | MP0002735_abnormal_chemical_nociception | 1.96918509 |
| 21 | MP0001440_abnormal_grooming_behavior | 1.94276102 |
| 22 | MP0005646_abnormal_pituitary_gland | 1.88969993 |
| 23 | MP0002733_abnormal_thermal_nociception | 1.85886253 |
| 24 | MP0002067_abnormal_sensory_capabilities | 1.82386423 |
| 25 | MP0001970_abnormal_pain_threshold | 1.81581749 |
| 26 | MP0003879_abnormal_hair_cell | 1.80459616 |
| 27 | MP0003787_abnormal_imprinting | 1.79172948 |
| 28 | MP0003283_abnormal_digestive_organ | 1.70249485 |
| 29 | MP0004858_abnormal_nervous_system | 1.69333199 |
| 30 | MP0008877_abnormal_DNA_methylation | 1.67870538 |
| 31 | MP0008569_lethality_at_weaning | 1.67721241 |
| 32 | MP0004811_abnormal_neuron_physiology | 1.64250889 |
| 33 | MP0002557_abnormal_social/conspecific_i | 1.63539156 |
| 34 | MP0002184_abnormal_innervation | 1.60670086 |
| 35 | MP0003329_amyloid_beta_deposits | 1.60636576 |
| 36 | MP0000778_abnormal_nervous_system | 1.53280875 |
| 37 | MP0002837_dystrophic_cardiac_calcinosis | 1.51152521 |
| 38 | MP0004924_abnormal_behavior | 1.45767673 |
| 39 | MP0005386_behavior/neurological_phenoty | 1.45767673 |
| 40 | MP0000955_abnormal_spinal_cord | 1.43256206 |
| 41 | MP0004885_abnormal_endolymph | 1.39288790 |
| 42 | MP0000013_abnormal_adipose_tissue | 1.35780554 |
| 43 | MP0003633_abnormal_nervous_system | 1.34807226 |
| 44 | MP0002066_abnormal_motor_capabilities/c | 1.32951545 |
| 45 | MP0006276_abnormal_autonomic_nervous | 1.32925628 |
| 46 | MP0004043_abnormal_pH_regulation | 1.30926764 |
| 47 | MP0002882_abnormal_neuron_morphology | 1.28680701 |
| 48 | MP0001502_abnormal_circadian_rhythm | 1.24188963 |
| 49 | MP0003121_genomic_imprinting | 1.19073155 |
| 50 | MP0005645_abnormal_hypothalamus_physiol | 1.17589749 |
| 51 | * MP0010386_abnormal_urinary_bladder | 1.16797066 |
| 52 | MP0001984_abnormal_olfaction | 1.15862036 |
| 53 | MP0001188_hyperpigmentation | 1.08086881 |
| 54 | * MP0002693_abnormal_pancreas_physiology | 1.04550841 |
| 55 | MP0008961_abnormal_basal_metabolism | 1.03551912 |
| 56 | MP0003631_nervous_system_phenotype | 1.02873980 |
| 57 | * MP0005535_abnormal_body_temperature | 1.01750394 |
| 58 | MP0004510_myositis | 1.01067192 |
| 59 | MP0004145_abnormal_muscle_electrophysio | 1.00898952 |
| 60 | MP0003122_maternal_imprinting | 0.98256176 |
| 61 | * MP0002069_abnormal_eating/drinking_beha | 0.97859767 |
| 62 | MP0002152_abnormal_brain_morphology | 0.97473221 |
| 63 | MP0002876_abnormal_thyroid_physiology | 0.95237109 |
| 64 | MP0001944_abnormal_pancreas_morphology | 0.93754708 |
| 65 | MP0003172_abnormal_lysosome_physiology | 0.90249545 |
| 66 | MP0002229_neurodegeneration | 0.90087210 |
| 67 | MP0003119_abnormal_digestive_system | 0.89564554 |
| 68 | MP0001905_abnormal_dopamine_level | 0.88216844 |
| 69 | MP0005379_endocrine/exocrine_gland_phen | 0.87978605 |
| 70 | MP0003690_abnormal_glial_cell | 0.87627918 |
| 71 | MP0003075_altered_response_to | 0.87171993 |
| 72 | MP0005551_abnormal_eye_electrophysiolog | 0.87149110 |
| 73 | MP0000639_abnormal_adrenal_gland | 0.86837479 |
| 74 | MP0003183_abnormal_peptide_metabolism | 0.85222329 |
| 75 | MP0000631_abnormal_neuroendocrine_gland | 0.85104977 |
| 76 | MP0000920_abnormal_myelination | 0.84588501 |
| 77 | MP0004085_abnormal_heartbeat | 0.84351834 |
| 78 | MP0001529_abnormal_vocalization | 0.83819655 |
| 79 | MP0004133_heterotaxia | 0.83301569 |
| 80 | MP0001765_abnormal_ion_homeostasis | 0.81490630 |
| 81 | MP0001177_atelectasis | 0.81162496 |
| 82 | MP0000678_abnormal_parathyroid_gland | 0.80448852 |
| 83 | MP0006072_abnormal_retinal_apoptosis | 0.79183428 |
| 84 | * MP0001664_abnormal_digestion | 0.79018514 |
| 85 | MP0001963_abnormal_hearing_physiology | 0.78959285 |
| 86 | MP0002234_abnormal_pharynx_morphology | 0.78958250 |
| 87 | MP0008874_decreased_physiological_sensi | 0.77950264 |
| 88 | MP0000566_synostosis | 0.76430713 |
| 89 | MP0008872_abnormal_physiological_respon | 0.76136822 |
| 90 | MP0005187_abnormal_penis_morphology | 0.75105824 |
| 91 | MP0004142_abnormal_muscle_tone | 0.74870666 |
| 92 | MP0004742_abnormal_vestibular_system | 0.73551762 |
| 93 | MP0003890_abnormal_embryonic-extraembry | 0.73057533 |
| 94 | MP0000569_abnormal_digit_pigmentation | 0.73008822 |
| 95 | MP0004484_altered_response_of | 0.72810006 |
| 96 | MP0005167_abnormal_blood-brain_barrier | 0.72648580 |
| 97 | MP0005253_abnormal_eye_physiology | 0.72077235 |
| 98 | MP0010234_abnormal_vibrissa_follicle | 0.70869688 |
| 99 | MP0003634_abnormal_glial_cell | 0.70505414 |
| 100 | MP0002638_abnormal_pupillary_reflex | 0.70142911 |
| 101 | * MP0002078_abnormal_glucose_homeostasis | 0.68848687 |
| 102 | MP0002090_abnormal_vision | 0.67284049 |
| 103 | MP0001485_abnormal_pinna_reflex | 0.66572283 |
| 104 | MP0003868_abnormal_feces_composition | 0.65152722 |
| 105 | MP0002877_abnormal_melanocyte_morpholog | 0.64914465 |
| 106 | MP0000604_amyloidosis | 0.63645673 |
| 107 | MP0010769_abnormal_survival | 0.63619060 |
| 108 | MP0010770_preweaning_lethality | 0.63040249 |
| 109 | MP0002082_postnatal_lethality | 0.63040249 |
| 110 | * MP0003953_abnormal_hormone_level | 0.60662605 |
| 111 | MP0010768_mortality/aging | 0.60412511 |
| 112 | MP0003861_abnormal_nervous_system | 0.60307459 |
| 113 | MP0004215_abnormal_myocardial_fiber | 0.60276889 |
| 114 | MP0003942_abnormal_urinary_system | 0.58849515 |
| 115 | MP0006292_abnormal_olfactory_placode | 0.58560054 |
| 116 | MP0003632_abnormal_nervous_system | 0.57747977 |
| 117 | MP0002752_abnormal_somatic_nervous | 0.56951088 |
| 118 | MP0002160_abnormal_reproductive_system | 0.54958533 |
| 119 | MP0003137_abnormal_impulse_conducting | 0.54285875 |
| 120 | MP0002751_abnormal_autonomic_nervous | 0.53614834 |
| 121 | MP0001346_abnormal_lacrimal_gland | 0.52724987 |
| 122 | MP0005195_abnormal_posterior_eye | 0.52640222 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.16642101 |
| 2 | Myokymia (HP:0002411) | 5.97015116 |
| 3 | Focal seizures (HP:0007359) | 5.65953783 |
| 4 | Visual hallucinations (HP:0002367) | 5.60101956 |
| 5 | Atonic seizures (HP:0010819) | 4.97212257 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.93299378 |
| 7 | Absence seizures (HP:0002121) | 4.46720752 |
| 8 | Febrile seizures (HP:0002373) | 4.40907869 |
| 9 | Progressive cerebellar ataxia (HP:0002073) | 4.23821766 |
| 10 | Generalized tonic-clonic seizures (HP:0002069) | 4.13353319 |
| 11 | Dialeptic seizures (HP:0011146) | 4.10869825 |
| 12 | Abnormality of the corticospinal tract (HP:0002492) | 3.96948386 |
| 13 | Hyperventilation (HP:0002883) | 3.93219211 |
| 14 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.87470665 |
| 15 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.87470665 |
| 16 | Limb dystonia (HP:0002451) | 3.65241117 |
| 17 | Broad-based gait (HP:0002136) | 3.42156665 |
| 18 | Supranuclear gaze palsy (HP:0000605) | 3.40428773 |
| 19 | Gait imbalance (HP:0002141) | 3.36679005 |
| 20 | Action tremor (HP:0002345) | 3.31374580 |
| 21 | Epileptiform EEG discharges (HP:0011182) | 3.27383024 |
| 22 | Depression (HP:0000716) | 3.21196790 |
| 23 | Amblyopia (HP:0000646) | 3.20350801 |
| 24 | Poor eye contact (HP:0000817) | 3.15254464 |
| 25 | Papilledema (HP:0001085) | 3.15061730 |
| 26 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.10371132 |
| 27 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.09734471 |
| 28 | Gaze-evoked nystagmus (HP:0000640) | 3.09561954 |
| 29 | EEG with generalized epileptiform discharges (HP:0011198) | 3.07405163 |
| 30 | Anxiety (HP:0000739) | 3.05298985 |
| 31 | Medial flaring of the eyebrow (HP:0010747) | 2.94688274 |
| 32 | True hermaphroditism (HP:0010459) | 2.94682870 |
| 33 | Truncal ataxia (HP:0002078) | 2.91044221 |
| 34 | Abnormal social behavior (HP:0012433) | 2.90202147 |
| 35 | Impaired social interactions (HP:0000735) | 2.90202147 |
| 36 | Drooling (HP:0002307) | 2.89683079 |
| 37 | Excessive salivation (HP:0003781) | 2.89683079 |
| 38 | Decreased circulating renin level (HP:0003351) | 2.89460072 |
| 39 | Dysmetria (HP:0001310) | 2.88154866 |
| 40 | Anomalous pulmonary venous return (HP:0010772) | 2.88046238 |
| 41 | Hypsarrhythmia (HP:0002521) | 2.86154811 |
| 42 | Amyotrophic lateral sclerosis (HP:0007354) | 2.85671340 |
| 43 | Dysdiadochokinesis (HP:0002075) | 2.85516482 |
| 44 | Ankle clonus (HP:0011448) | 2.83078932 |
| 45 | Cerebral inclusion bodies (HP:0100314) | 2.80336689 |
| 46 | Gonadal dysgenesis (HP:0000133) | 2.77677486 |
| 47 | Congenital primary aphakia (HP:0007707) | 2.77120569 |
| 48 | Impaired smooth pursuit (HP:0007772) | 2.71980921 |
| 49 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.67971276 |
| 50 | Postural instability (HP:0002172) | 2.64313999 |
| 51 | Genetic anticipation (HP:0003743) | 2.63640573 |
| 52 | Neurofibrillary tangles (HP:0002185) | 2.63060469 |
| 53 | Absent speech (HP:0001344) | 2.58313668 |
| 54 | Testicular neoplasm (HP:0010788) | 2.57073438 |
| 55 | Abnormal eating behavior (HP:0100738) | 2.56961135 |
| 56 | Hemiparesis (HP:0001269) | 2.55912203 |
| 57 | Nephrogenic diabetes insipidus (HP:0009806) | 2.53755854 |
| 58 | Agitation (HP:0000713) | 2.51788008 |
| 59 | Ventricular fibrillation (HP:0001663) | 2.51185258 |
| 60 | Bradykinesia (HP:0002067) | 2.49542115 |
| 61 | Abnormality of the pulmonary veins (HP:0011718) | 2.48185883 |
| 62 | Vaginal atresia (HP:0000148) | 2.47556067 |
| 63 | Abnormality of binocular vision (HP:0011514) | 2.43378549 |
| 64 | Diplopia (HP:0000651) | 2.43378549 |
| 65 | Genital tract atresia (HP:0001827) | 2.42430571 |
| 66 | Mutism (HP:0002300) | 2.40886912 |
| 67 | Blue irides (HP:0000635) | 2.40568553 |
| 68 | Abnormality of the lower motor neuron (HP:0002366) | 2.27325125 |
| 69 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.25787305 |
| 70 | Mesangial abnormality (HP:0001966) | 2.25343635 |
| 71 | Stereotypic behavior (HP:0000733) | 2.24274819 |
| 72 | Impaired vibratory sensation (HP:0002495) | 2.20630301 |
| 73 | Polyphagia (HP:0002591) | 2.20478834 |
| 74 | Hemiplegia (HP:0002301) | 2.19267495 |
| 75 | Progressive inability to walk (HP:0002505) | 2.17220105 |
| 76 | Spastic gait (HP:0002064) | 2.17214116 |
| 77 | Ulnar claw (HP:0001178) | 2.17136694 |
| 78 | Protruding tongue (HP:0010808) | 2.17076928 |
| 79 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.16615361 |
| 80 | Chronic hepatic failure (HP:0100626) | 2.15879935 |
| 81 | Neuroendocrine neoplasm (HP:0100634) | 2.15797829 |
| 82 | Scanning speech (HP:0002168) | 2.13804241 |
| 83 | Focal dystonia (HP:0004373) | 2.12800664 |
| 84 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.11372869 |
| 85 | Generalized myoclonic seizures (HP:0002123) | 2.11130425 |
| 86 | Intention tremor (HP:0002080) | 2.11009696 |
| 87 | Paraplegia (HP:0010550) | 2.10136525 |
| 88 | Megalencephaly (HP:0001355) | 2.09473322 |
| 89 | Specific learning disability (HP:0001328) | 2.09326342 |
| 90 | Torticollis (HP:0000473) | 2.08689514 |
| 91 | Inability to walk (HP:0002540) | 2.07482149 |
| 92 | Insidious onset (HP:0003587) | 2.06176083 |
| 93 | Termporal pattern (HP:0011008) | 2.06176083 |
| 94 | Hypothermia (HP:0002045) | 2.02806563 |
| 95 | Status epilepticus (HP:0002133) | 2.01685753 |
| 96 | Bundle branch block (HP:0011710) | 2.00242584 |
| 97 | Spastic tetraplegia (HP:0002510) | 1.99651641 |
| 98 | Tetraplegia (HP:0002445) | 1.98498800 |
| 99 | Urinary urgency (HP:0000012) | 1.96471652 |
| 100 | Generalized hypopigmentation of hair (HP:0011358) | 1.96120706 |
| 101 | Type II lissencephaly (HP:0007260) | 1.93732772 |
| 102 | Poor coordination (HP:0002370) | 1.93377087 |
| 103 | Gait ataxia (HP:0002066) | 1.92372158 |
| 104 | Nephronophthisis (HP:0000090) | 1.88100875 |
| 105 | Increased circulating renin level (HP:0000848) | 1.87718179 |
| 106 | Spastic paraplegia (HP:0001258) | 1.86493222 |
| 107 | Delusions (HP:0000746) | 1.86162961 |
| 108 | Dysmetric saccades (HP:0000641) | 1.85841700 |
| 109 | Fetal akinesia sequence (HP:0001989) | 1.85703853 |
| 110 | Psychosis (HP:0000709) | 1.85166206 |
| 111 | Retinal dysplasia (HP:0007973) | 1.83715179 |
| 112 | Clonus (HP:0002169) | 1.82959042 |
| 113 | Pheochromocytoma (HP:0002666) | 1.82912055 |
| 114 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.80703811 |
| 115 | Hyperactive renin-angiotensin system (HP:0000841) | 1.80570698 |
| 116 | Resting tremor (HP:0002322) | 1.80509498 |
| 117 | Cerebral hypomyelination (HP:0006808) | 1.79797722 |
| 118 | Akinesia (HP:0002304) | 1.79451906 |
| 119 | Ankyloglossia (HP:0010296) | 1.77710063 |
| 120 | Craniofacial dystonia (HP:0012179) | 1.76620522 |
| 121 | * Abnormality of salivation (HP:0100755) | 1.76385159 |
| 122 | Incomplete penetrance (HP:0003829) | 1.76335814 |
| 123 | Widely spaced teeth (HP:0000687) | 1.74556508 |
| 124 | Male pseudohermaphroditism (HP:0000037) | 1.73993557 |
| 125 | Neuronal loss in central nervous system (HP:0002529) | 1.73857848 |
| 126 | Abnormal EKG (HP:0003115) | 1.73642046 |
| 127 | Abnormality of renin-angiotensin system (HP:0000847) | 1.73396146 |
| 128 | Hypoglycemic seizures (HP:0002173) | 1.72033800 |
| 129 | Lower limb muscle weakness (HP:0007340) | 1.71603081 |
| 130 | Transposition of the great arteries (HP:0001669) | 1.71453690 |
| 131 | Abnormal connection of the cardiac segments (HP:0011545) | 1.71453690 |
| 132 | Abnormal ventriculo-arterial connection (HP:0011563) | 1.71453690 |
| 133 | Symptomatic seizures (HP:0011145) | 1.70597329 |
| 134 | Central scotoma (HP:0000603) | 1.69766074 |
| 135 | Rapidly progressive (HP:0003678) | 1.69522513 |
| 136 | Thickened helices (HP:0000391) | 1.66693963 |
| 137 | Inappropriate behavior (HP:0000719) | 1.66464605 |
| 138 | Pancreatic cysts (HP:0001737) | 1.61372626 |
| 139 | Syncope (HP:0001279) | 1.57319349 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.70832137 |
| 2 | EPHA4 | 4.48088436 |
| 3 | MAP3K9 | 3.62990933 |
| 4 | NEK1 | 3.56180241 |
| 5 | MAP3K4 | 2.98932386 |
| 6 | PRKD3 | 2.81812616 |
| 7 | DAPK2 | 2.75083297 |
| 8 | MAP4K2 | 2.63628946 |
| 9 | MAP2K7 | 2.58809624 |
| 10 | RIPK4 | 2.58770119 |
| 11 | MARK1 | 2.41023720 |
| 12 | MINK1 | 2.34131463 |
| 13 | PAK6 | 2.18897418 |
| 14 | KSR2 | 2.06754293 |
| 15 | CASK | 1.97333082 |
| 16 | NTRK1 | 1.93174686 |
| 17 | MAP2K4 | 1.88619341 |
| 18 | ADRBK2 | 1.79592055 |
| 19 | CAMKK1 | 1.79249077 |
| 20 | MAP3K12 | 1.76020517 |
| 21 | DAPK1 | 1.75042901 |
| 22 | NTRK2 | 1.57322085 |
| 23 | CDK5 | 1.53882824 |
| 24 | PLK2 | 1.51970521 |
| 25 | MAP3K2 | 1.51105157 |
| 26 | INSRR | 1.47067851 |
| 27 | GRK5 | 1.46762404 |
| 28 | KSR1 | 1.45631846 |
| 29 | BMPR2 | 1.33234809 |
| 30 | STK38 | 1.29947021 |
| 31 | TNIK | 1.27876621 |
| 32 | CDK19 | 1.25966337 |
| 33 | SIK2 | 1.22497241 |
| 34 | FES | 1.22222743 |
| 35 | PRPF4B | 1.21408468 |
| 36 | PNCK | 1.19485357 |
| 37 | PRKCG | 1.17912544 |
| 38 | CCNB1 | 1.15102462 |
| 39 | NME1 | 1.10461008 |
| 40 | ARAF | 1.10313708 |
| 41 | MAP3K13 | 1.04643051 |
| 42 | CAMK2A | 1.04497767 |
| 43 | MAPK13 | 1.03209478 |
| 44 | MAP3K1 | 1.00212132 |
| 45 | UHMK1 | 0.97960429 |
| 46 | CAMK1 | 0.97275630 |
| 47 | CAMKK2 | 0.95608924 |
| 48 | PTK2B | 0.95600005 |
| 49 | CAMK2B | 0.94629916 |
| 50 | PRKCH | 0.93857598 |
| 51 | STK39 | 0.90399988 |
| 52 | STK11 | 0.89185465 |
| 53 | TYRO3 | 0.89124476 |
| 54 | RET | 0.87548814 |
| 55 | RAF1 | 0.83828948 |
| 56 | CSNK1G1 | 0.80134980 |
| 57 | TAOK1 | 0.78710060 |
| 58 | OXSR1 | 0.75250103 |
| 59 | PDK1 | 0.74798878 |
| 60 | PAK3 | 0.73748830 |
| 61 | DYRK1A | 0.72269374 |
| 62 | SGK223 | 0.69862939 |
| 63 | SGK494 | 0.69862939 |
| 64 | RIPK1 | 0.68629779 |
| 65 | PDPK1 | 0.68477778 |
| 66 | AKT3 | 0.68350829 |
| 67 | FER | 0.68085754 |
| 68 | SGK1 | 0.67541065 |
| 69 | CSNK1G3 | 0.67450222 |
| 70 | PLK4 | 0.66785189 |
| 71 | MARK2 | 0.64336068 |
| 72 | CDK18 | 0.63843486 |
| 73 | NEK2 | 0.63778397 |
| 74 | CDK15 | 0.63739882 |
| 75 | SGK2 | 0.63591567 |
| 76 | PRKCE | 0.63104847 |
| 77 | LMTK2 | 0.62871312 |
| 78 | DYRK2 | 0.62624303 |
| 79 | ALK | 0.61215100 |
| 80 | CAMK4 | 0.61162768 |
| 81 | FGR | 0.61003395 |
| 82 | CDC42BPA | 0.60734062 |
| 83 | BMPR1B | 0.60493892 |
| 84 | CDK14 | 0.60429561 |
| 85 | TAOK3 | 0.60070552 |
| 86 | HIPK2 | 0.59293205 |
| 87 | MAP3K7 | 0.58895072 |
| 88 | SGK3 | 0.57900241 |
| 89 | CSNK1G2 | 0.57267774 |
| 90 | LATS2 | 0.56287075 |
| 91 | PINK1 | 0.56091186 |
| 92 | DMPK | 0.55438214 |
| 93 | EIF2AK3 | 0.54891220 |
| 94 | CDK11A | 0.53792885 |
| 95 | NEK6 | 0.53255701 |
| 96 | CAMK1G | 0.53243181 |
| 97 | CAMK2D | 0.52492187 |
| 98 | CSNK1A1 | 0.51980769 |
| 99 | MAPKAPK5 | 0.50880772 |
| 100 | WNK4 | 0.49415177 |
| 101 | ADRBK1 | 0.48571234 |
| 102 | WNK3 | 0.48243532 |
| 103 | CSNK1E | 0.48200790 |
| 104 | FRK | 0.48043966 |
| 105 | PRKCZ | 0.47362377 |
| 106 | RPS6KA3 | 0.44630461 |
| 107 | TNK2 | 0.44496962 |
| 108 | CSNK1A1L | 0.44248361 |
| 109 | MAP2K1 | 0.43557753 |
| 110 | PHKG2 | 0.42907510 |
| 111 | PHKG1 | 0.42907510 |
| 112 | PRKACA | 0.42358696 |
| 113 | MAP3K6 | 0.42349257 |
| 114 | RPS6KB1 | 0.42049354 |
| 115 | MAPK12 | 0.41937573 |
| 116 | MUSK | 0.41059652 |
| 117 | PRKG1 | 0.40789726 |
| 118 | BCR | 0.40182465 |
| 119 | FYN | 0.38347925 |
| 120 | FGFR2 | 0.38283955 |
| 121 | PRKD2 | 0.38194140 |
| 122 | MAPK10 | 0.37966285 |
| 123 | SCYL2 | 0.37457309 |
| 124 | ACVR1B | 0.37394868 |
| 125 | PRKCA | 0.36179464 |
| 126 | CAMK2G | 0.34949880 |
| 127 | PRKCB | 0.34625529 |
| 128 | TIE1 | 0.34333015 |
| 129 | PIK3CG | 0.32466643 |
| 130 | CSNK1D | 0.32311765 |
| 131 | PRKACB | 0.31650369 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.54754639 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.02514869 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.79932789 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.68261374 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.67542518 |
| 6 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.59078689 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.52711362 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.51968209 |
| 9 | * Insulin secretion_Homo sapiens_hsa04911 | 2.51316878 |
| 10 | Olfactory transduction_Homo sapiens_hsa04740 | 2.40864892 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 2.37332425 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.20244479 |
| 13 | * Salivary secretion_Homo sapiens_hsa04970 | 2.18761259 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.09794898 |
| 15 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.95572227 |
| 16 | * Taste transduction_Homo sapiens_hsa04742 | 1.84633909 |
| 17 | * Cholinergic synapse_Homo sapiens_hsa04725 | 1.80835101 |
| 18 | * Gastric acid secretion_Homo sapiens_hsa04971 | 1.78150212 |
| 19 | Renin secretion_Homo sapiens_hsa04924 | 1.73948795 |
| 20 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.63007239 |
| 21 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.61743378 |
| 22 | Long-term depression_Homo sapiens_hsa04730 | 1.57385693 |
| 23 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.55832415 |
| 24 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.55117085 |
| 25 | Cocaine addiction_Homo sapiens_hsa05030 | 1.54832666 |
| 26 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.54161260 |
| 27 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.54082564 |
| 28 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.44150681 |
| 29 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.39700328 |
| 30 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.37079281 |
| 31 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.29744807 |
| 32 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.24540662 |
| 33 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.24143976 |
| 34 | Gap junction_Homo sapiens_hsa04540 | 1.23516059 |
| 35 | * Pancreatic secretion_Homo sapiens_hsa04972 | 1.22910617 |
| 36 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.22692438 |
| 37 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.20187256 |
| 38 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.19578643 |
| 39 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.16356887 |
| 40 | Glioma_Homo sapiens_hsa05214 | 1.14157777 |
| 41 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.13665710 |
| 42 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.07458939 |
| 43 | Melanogenesis_Homo sapiens_hsa04916 | 1.04472842 |
| 44 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.99757991 |
| 45 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.98689216 |
| 46 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.98430798 |
| 47 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.98202201 |
| 48 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.95369707 |
| 49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.91556404 |
| 50 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.91367591 |
| 51 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.91365200 |
| 52 | Axon guidance_Homo sapiens_hsa04360 | 0.88355203 |
| 53 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.86174939 |
| 54 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.81828420 |
| 55 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.79186776 |
| 56 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.76902399 |
| 57 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.75867036 |
| 58 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.72627090 |
| 59 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.70070837 |
| 60 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.69870738 |
| 61 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68644096 |
| 62 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.67807644 |
| 63 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.65166108 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65139548 |
| 65 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.63761519 |
| 66 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.63071673 |
| 67 | Phototransduction_Homo sapiens_hsa04744 | 0.61986415 |
| 68 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.58401576 |
| 69 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.57963981 |
| 70 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.56410740 |
| 71 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.55628206 |
| 72 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.54706469 |
| 73 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.54024338 |
| 74 | Circadian rhythm_Homo sapiens_hsa04710 | 0.53667404 |
| 75 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.53642204 |
| 76 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.52445617 |
| 77 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.49984891 |
| 78 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.49968030 |
| 79 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.49756804 |
| 80 | Prion diseases_Homo sapiens_hsa05020 | 0.47277138 |
| 81 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.46899884 |
| 82 | Endometrial cancer_Homo sapiens_hsa05213 | 0.46777569 |
| 83 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.46173561 |
| 84 | Alzheimers disease_Homo sapiens_hsa05010 | 0.43757930 |
| 85 | Histidine metabolism_Homo sapiens_hsa00340 | 0.43643253 |
| 86 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.43544141 |
| 87 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.43185273 |
| 88 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.43076175 |
| 89 | Bile secretion_Homo sapiens_hsa04976 | 0.42967309 |
| 90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42590233 |
| 91 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42308511 |
| 92 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.41684113 |
| 93 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.41298028 |
| 94 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.39002561 |
| 95 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.37753442 |
| 96 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.37598849 |
| 97 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37546152 |
| 98 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.36850417 |
| 99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.36648997 |
| 100 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.36640037 |
| 101 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.35742913 |
| 102 | Endocytosis_Homo sapiens_hsa04144 | 0.35155647 |
| 103 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.34966116 |
| 104 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.34860920 |
| 105 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.33709442 |
| 106 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.33013597 |
| 107 | ABC transporters_Homo sapiens_hsa02010 | 0.32511694 |
| 108 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32315749 |
| 109 | Alcoholism_Homo sapiens_hsa05034 | 0.32233875 |
| 110 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.31946511 |
| 111 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.31744179 |
| 112 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.31629434 |
| 113 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.29674942 |
| 114 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.29384973 |
| 115 | Tight junction_Homo sapiens_hsa04530 | 0.28931344 |
| 116 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.28464714 |
| 117 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.27624703 |
| 118 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.27092422 |
| 119 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.25757002 |
| 120 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.24700256 |
| 121 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.22115225 |
| 122 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.21769656 |
| 123 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.21019770 |

